Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Boccia

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
The Journal of Supportive Oncology|March 30, 2005
Darbepoetin alfa in anemia management: a vital role in cancer careRalph Boccia
Seminars in Oncology|February 11, 2003
Improved tolerability of amifostine with rapid infusion and optimal patient preparationRalph Boccia
The Journal of Community and Supportive Oncology|April 14, 2015
Sustained antiemetic responses with APF530 (sustained-release granisetron) during multiple cycles of emetogenic chemotherapyRalph Boccia, William Cooper, Erin O'Boyle
BMC Cancer|February 28, 2016
Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapyRalph Boccia, Erin O'Boyle, William Cooper
The Oncologist|May 13, 2022
Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?Ralph Boccia, John Glaspy, Jeffrey Crawford, et al.
The Oncologist|May 25, 2007
The effectiveness of darbepoetin alfa administered every 3 weeks on hematologic outcomes and quality of life in older patients with chemotherapy-induced anemiaRalph Boccia, Tom Lillie, Dianne Tomita, et al.
Drugs - Real World Outcomes|March 19, 2024
Effect of Ferric Carboxymaltose Versus Low-Dose Intravenous Iron Therapy and Iron Sucrose on the Total Cost of Care in Patients with Iron Deficiency Anemia: A US Claims Database AnalysisWinghan Jacqueline Kwong, Kevin Wang, Peng Wang, et al.
Future Oncology (London, England)|October 11, 2018
Hypersensitivity and infusion-site adverse events with intravenous fosaprepitant after anthracycline-containing chemotherapy: a retrospective studyRalph Boccia, Robert B Geller, Neil Clendeninn, et al.
Cancer Management and Research|June 16, 2017
Can biosimilars help achieve the goals of US health care reform?Ralph Boccia, Ira Jacobs, Robert Popovian, et al.
Expert Review of Hematology|November 1, 2021
Immune thrombocytopeniaJames Bussel, Nichola Cooper, Ralph Boccia, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Supportive Oncology|March 30, 2005
Darbepoetin alfa in anemia management: a vital role in cancer careRalph Boccia
Seminars in Oncology|February 11, 2003
Improved tolerability of amifostine with rapid infusion and optimal patient preparationRalph Boccia
The Journal of Community and Supportive Oncology|April 14, 2015
Sustained antiemetic responses with APF530 (sustained-release granisetron) during multiple cycles of emetogenic chemotherapyRalph Boccia, William Cooper, Erin O'Boyle
BMC Cancer|February 28, 2016
Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapyRalph Boccia, Erin O'Boyle, William Cooper
The Oncologist|May 13, 2022
Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?Ralph Boccia, John Glaspy, Jeffrey Crawford, et al.
The Oncologist|May 25, 2007
The effectiveness of darbepoetin alfa administered every 3 weeks on hematologic outcomes and quality of life in older patients with chemotherapy-induced anemiaRalph Boccia, Tom Lillie, Dianne Tomita, et al.
Drugs - Real World Outcomes|March 19, 2024
Effect of Ferric Carboxymaltose Versus Low-Dose Intravenous Iron Therapy and Iron Sucrose on the Total Cost of Care in Patients with Iron Deficiency Anemia: A US Claims Database AnalysisWinghan Jacqueline Kwong, Kevin Wang, Peng Wang, et al.
Future Oncology (London, England)|October 11, 2018
Hypersensitivity and infusion-site adverse events with intravenous fosaprepitant after anthracycline-containing chemotherapy: a retrospective studyRalph Boccia, Robert B Geller, Neil Clendeninn, et al.
Cancer Management and Research|June 16, 2017
Can biosimilars help achieve the goals of US health care reform?Ralph Boccia, Ira Jacobs, Robert Popovian, et al.
Expert Review of Hematology|November 1, 2021
Immune thrombocytopeniaJames Bussel, Nichola Cooper, Ralph Boccia, et al.
Pageof 5